Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionWbh Advisory Inc
Latest Disclosed Ownership5,257 shares
Latest Disclosed Value $ 324,524
Wbh Advisory Inc reports 19.29% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 27, 2026 - Wbh Advisory Inc filed a 13F-HR form disclosing ownership of 5,257 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $275,572 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 4,407 shares of Bristol-Myers Squibb Company. This represents a change in shares of 19.29% during the quarter. The current value of the position is $249,340 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,257 850 19.29 325 36.71 0.0243
2026-01-26 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,407 4,407 238 0.0176
2025-07-30 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -4,473 -100.00 0 -100.00
2025-05-12 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,473 3 0.07 273 7.94 0.0255
2025-01-31 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,470 -154 -3.33 253 5.44 0.0235
2024-10-15 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 4,624 -1,200 -20.60 239 -0.83 0.0227
2024-07-11 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,824 -2,969 -33.77 242 -49.37 0.0245
2024-04-16 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,793 -1,756 -16.65 477 -12.01 0.0491
2024-01-09 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 10,549 -628 -5.62 541 -16.51 0.0602
2023-10-10 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,177 -236 -2.07 649 -11.11 0.0796
2023-07-12 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,413 -640 -5.31 730 -12.69 0.0865
2023-04-20 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,053 -719 -5.63 835 -8.04 0.1043
2022-10-18 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,772 1 0.01 908 -5.91 0.1310
2022-07-12 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,771 -634 -4.73 965 -6.76 0.1288
2022-04-29 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,405 -1,668 -11.07 1,035 10.11 0.1270
2022-01-28 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,073 -2,582 -14.62 940 -10.05 0.1072
2021-10-25 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,655 -268 -1.50 1,045 -13.85 0.1406
2021-07-27 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,923 -1,992 -10.00 1,213 -3.50 0.1778
2021-04-19 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 19,915 -142 -0.71 1,257 -5.42 0.2034
2021-01-21 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 20,057 -471 -2.29 1,329 7.35 0.2287
2020-10-27 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 20,528 -903 -4.21 1,238 -1.75 0.2499
2020-08-05 2020-06-30 13F Bristol Myers COM 110122108 21,431 441 2.10 1,260 7.78 0.3049
2020-05-07 2020-03-31 13F Bristol Myers COM 110122108 20,990 692 3.41 1,169 -10.22 0.2742
2020-01-27 2019-12-31 13F Bristol Myers COM 110122108 20,298 2,929 16.86 1,302 47.95 0.2662
2019-10-25 2019-09-30 13F Bristol Myers COM 110122108 17,369 -355 -2.00 880 9.59 0.1976
2019-08-02 2019-06-30 13F Bristol Myers COM 110122108 17,724 -375 -2.07 803 -6.95 0.1862
2019-04-22 2019-03-31 13F Bristol Myers COM 110122108 18,099 113 0.63 863 -7.60 0.2053
2019-01-29 2018-12-31 13F Bristol Myers COM 110122108 17,986 -976 -5.15 934 -20.65 0.2268
2018-10-29 2018-09-30 13F Bristol Myers COM 110122108 18,962 -109 -0.57 1,177 11.56 0.2853
2018-07-31 2018-06-30 13F Bristol Myers COM 110122108 19,071 66 0.35 1,055 -12.23 0.2735
2018-04-30 2018-03-31 13F Bristol Myers COM 110122108 19,005 414 2.23 1,202 5.53 0.3268
2018-01-31 2017-12-31 13F Bristol Myers COM 110122108 18,591 -46 -0.25 1,139 -4.04 0.3038
2017-11-29 2017-09-30 13F Bristol Myers COM 110122108 18,637 -710 -3.67 1,187 10.11 0.3313
2017-07-21 2017-06-30 13F Bristol Myers COM 110122108 19,347 -361 -1.83 1,078 0.65 0.3024
2017-04-21 2017-03-31 13F Bristol Myers COM 110122108 19,708 662 3.48 1,071 -3.77 0.3208
2017-01-20 2016-12-31 13F Bristol Myers COM 110122108 19,046 -39 -0.20 1,113 8.16 0.3710
2016-10-24 2016-09-30 13F Bristol Myers COM 110122108 19,085 3,821 25.03 1,029 -8.29 0.3521
2016-07-25 2016-06-30 13F Bristol Myers COM 110122108 15,264 -41 -0.27 1,122 14.84 0.4367
2016-04-15 2016-03-31 13F Bristol Myers COM 110122108 15,305 191 1.26 977 -5.97 0.3270
2016-01-19 2015-12-31 13F Bristol Myers COM 110122108 15,114 -181 -1.18 1,039 14.81 0.3631
2015-10-15 2015-09-30 13F Bristol Myers COM 110122108 15,295 -183 -1.18 905 -12.05 0.3760
2015-07-20 2015-06-30 13F Bristol Myers COM 110122108 15,478 -135 -0.86 1,029 2.18 0.4044
2015-04-22 2015-03-31 13F Bristol Myers COM 110122108 15,613 -220 -1.39 1,007 7.82 0.2825
2015-01-23 2014-12-31 13F Bristol Myers COM 110122108 15,833 -416 -2.56 934 12.39 0.3522
2014-10-17 2014-09-30 13F Bristol Myers COM 110122108 16,249 -527 -3.14 831 2.21 0.2920
2014-07-21 2014-06-30 13F Bristol Myers COM 110122108 16,776 213 1.29 813 -5.47 0.3074
2014-04-29 2014-03-31 13F Bristol Myers COM 110122108 16,563 187 1.14 860 -1.15 0.3421
2014-02-19 2013-12-31 13F/A-1 Bristol Myers COM 110122108 16,376 385 2.41 870 17.57 0.3504
2014-01-27 2013-12-31 13F Bristol Myers COM 110122108 16,376 870
2013-11-05 2013-09-30 13F Bristol Myers COM 110122108 15,991 84 0.53 740 4.23 0.3312
2013-07-19 2013-06-30 13F Bristol Myers COM 110122108 15,907 15,907 710 0.3284
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.